0000051143falseCHX00000511432024-07-242024-07-240000051143us-gaap:CommonStockMemberexch:XNYS2024-07-242024-07-240000051143us-gaap:CommonStockMemberexch:XCHI2024-07-242024-07-240000051143exch:XNYSibm:Notes1.125PercentDue2024Member2024-07-242024-07-240000051143ibm:Notes2.875PercentDue2025Memberexch:XNYS2024-07-242024-07-240000051143exch:XNYSibm:Notes0.950PercentDue2025Member2024-07-242024-07-240000051143exch:XNYSibm:Notes0.875PercentDue2025Member2024-07-242024-07-240000051143exch:XNYSibm:Notes0.300PercentDue2026Member2024-07-242024-07-240000051143ibm:Notes1.250PercentDue2027Memberexch:XNYS2024-07-242024-07-240000051143exch:XNYSibm:A3375NotesDue2027Member2024-07-242024-07-240000051143ibm:Notes0.300PercentDue2028Memberexch:XNYS2024-07-242024-07-240000051143ibm:Notes1.750PercentDue2028Memberexch:XNYS2024-07-242024-07-240000051143exch:XNYSibm:Notes1.500PercentDue2029Member2024-07-242024-07-240000051143exch:XNYSibm:Notes0.875PercentDue2030Member2024-07-242024-07-240000051143exch:XNYSibm:Notes1.750PercentDue2031Member2024-07-242024-07-240000051143exch:XNYSibm:A3625NotesDue2031Member2024-07-242024-07-240000051143exch:XNYSibm:Notes0.650PercentDue2032Member2024-07-242024-07-240000051143exch:XNYSibm:Notes1.250PercentDue2034Member2024-07-242024-07-240000051143exch:XNYSibm:A3750NotesDue2035Member2024-07-242024-07-240000051143exch:XNYSibm:A4875NotesDue2038Member2024-07-242024-07-240000051143exch:XNYSibm:Notes1.200PercentDue2040Member2024-07-242024-07-240000051143ibm:A4000NotesDue2043Memberexch:XNYS2024-07-242024-07-240000051143exch:XNYSibm:Debentures7.00PercentDue2025Member2024-07-242024-07-240000051143exch:XNYSibm:Debentures6.22PercentDue2027Member2024-07-242024-07-240000051143exch:XNYSibm:Debentures6.50PercentDue2028Member2024-07-242024-07-240000051143exch:XNYSibm:Debentures5.875PercentDue2032Member2024-07-242024-07-240000051143ibm:Debentures7.00PercentDue2045Memberexch:XNYS2024-07-242024-07-240000051143exch:XNYSibm:Debentures7.125PercentDue2096Member2024-07-242024-07-24

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT PURSUANT TO SECTION 13 OR 15 (d)
OF THE SECURITIES EXCHANGE ACT OF 1934
Date of Report: July 24, 2024
(Date of earliest event reported)
INTERNATIONAL BUSINESS MACHINES CORPORATION
(Exact name of registrant as specified in its charter)
New York 1-236013-0871985
(State of Incorporation)(Commission File Number)(IRS employer Identification No.)
One New Orchard Road
Armonk, New York
10504
(Address of principal executive offices)(Zip Code)
914-499-1900
(Registrant’s telephone number)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading symbol(s)Name of each exchange on which registered
Capital stock, par value $.20 per shareIBMNew York Stock Exchange
NYSE Chicago
1.125% Notes due 2024IBM 24ANew York Stock Exchange
2.875% Notes due 2025IBM 25ANew York Stock Exchange
0.950% Notes due 2025IBM 25BNew York Stock Exchange
0.875% Notes due 2025IBM 25CNew York Stock Exchange
0.300% Notes due 2026IBM 26BNew York Stock Exchange
1.250% Notes due 2027IBM 27BNew York Stock Exchange
3.375% Notes due 2027IBM 27FNew York Stock Exchange
0.300% Notes due 2028IBM 28BNew York Stock Exchange
1.750% Notes due 2028IBM 28ANew York Stock Exchange
1.500% Notes due 2029IBM 29New York Stock Exchange
0.875% Notes due 2030IBM 30ANew York Stock Exchange
1.750% Notes due 2031IBM 31New York Stock Exchange
3.625% Notes due 2031IBM 31BNew York Stock Exchange
0.650% Notes due 2032IBM 32ANew York Stock Exchange
1.250% Notes due 2034IBM 34New York Stock Exchange
3.750% Notes due 2035IBM 35New York Stock Exchange
4.875% Notes due 2038IBM 38New York Stock Exchange
1.200% Notes due 2040IBM 40New York Stock Exchange
4.000% Notes due 2043IBM 43New York Stock Exchange
7.00% Debentures due 2025IBM 25New York Stock Exchange
6.22% Debentures due 2027IBM 27New York Stock Exchange
6.50% Debentures due 2028IBM 28New York Stock Exchange
5.875% Debentures due 2032IBM 32DNew York Stock Exchange
7.00% Debentures due 2045IBM 45New York Stock Exchange
7.125% Debentures due 2096IBM 96New York Stock Exchange
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐


Item 2.02. Results of Operations and Financial Condition.
The registrant’s press release dated July 24, 2024, regarding its financial results for the period ended June 30, 2024, including consolidated financial statements for the period ended June 30, 2024, is Exhibit 99.1 of this Form 8-K.
In an effort to provide investors with additional information regarding the company’s results as determined by generally accepted accounting principles (GAAP), the company has disclosed in the attached press release certain non-GAAP information which management believes provides useful information to investors. Reconciliations of these non-GAAP financial measures to the most directly comparable financial measures calculated and presented in accordance with GAAP are included in the press release, which is Exhibit 99.1 to this Form 8-K. The rationale for management’s use of non-GAAP measures is included in Exhibit 99.2 to this Form 8-K.
The information in this Item 2.02, including the corresponding Exhibits 99.1 and 99.2, is being furnished with the Commission and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934.
Item 9.01. Financial Statements and Exhibits.
(d)Exhibits
The following exhibits are being furnished as part of this report:
Exhibit No.Description of Exhibit
99.1
99.2

The following exhibit is being filed as part of this report:
Exhibit No.Description of Exhibit
104Cover Page Interactive Data File (embedded within the Inline XBRL Document)

IBM’s web site (www.ibm.com) contains a significant amount of information about IBM, including financial and other information for investors (www.ibm.com/investor/). IBM encourages investors to visit its various web sites from time to time, as information is updated and new information is posted.
2

SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.
Date: July 24, 2024
By:/s/ Nicolás A. Fehring
Nicolás A. Fehring
Vice President and Controller
3